ClinicalTrials.gov
ClinicalTrials.gov Menu

Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia (XCL1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01380587
Recruitment Status : Completed
First Posted : June 27, 2011
Last Update Posted : August 27, 2013
Sponsor:
Information provided by (Responsible Party):
David Gomez Almaguer, Hospital Universitario Dr. Jose E. Gonzalez